Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation

Whan Lee, Cheol; Ahn, Jung‐Min; Park, Duk‐Woo; Kang, Soo‐Jin; Lee, Seung‐Whan; Kim, Young‐Hak; Park, Seong‐Wook; Han, Seungbong; Lee, Sang-Gon; Whan Seong, In; Rha, Seung‐Woon; Jeong, Myung‐Ho; Lim, Do‐Sun; Yoon, Junghan; Hur, Seung‐Ho; Choi, Yunseok; Yang, Joo‐Young; Lee, Nae‐Hee; Kim, Hyun‐Sook; Lee, Bong‐Ki; Kim, Kee‐Sik; Lee, Seunguk; Chae, Jei-Keon; Cheong, Sang‐Sig; Suh, Il‐Woo; Park, Hun‐Sik; Nah, Deuk-Young; Jeon, Doo‐Soo; Seung, Ki‐Bae; Lee, Keun; Jang, Jae‐Sik; Park, Seung‐Jung

doi:10.1161/circulationaha.113.003303

Public

Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation

Published in Circulation • Oct 5, 2013

Authors:

Cheol Whan Lee

Jung‐Min Ahn

Duk‐Woo Park

Abstract

BACKGROUND: The risks and benefits of long-term dual antiplatelet therapy remain unclear. METHODS AND RESULTS: This prospective, multicenter, open-label, randomized comparison trial was conducted in 24 clinical centers in Korea. In total, 5045 patients who received drug-eluting stents and were free ...

Subject

Medicine

Aspirin

Hazard ratio

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!